Marizyme, Inc. (MRZM)

Marizyme Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-69.02	-65.35	-62.18	-9.74	-5.89	-1.06
Depreciation & Amortization	0.84	0.84	0.84	0.04	0.59	0
Share-Based Compensation	0.37	0.53	1.91	0.9	1.33	0.7
Other Operating Activities	63.35	59.06	48.58	3.01	0.75	0.25
Operating Cash Flow	-4.46	-4.91	-10.85	-5.79	-3.22	-0.11
Capital Expenditures	0	0	0	0	-0.15	-0.01
Investing Cash Flow	0	0	0	0	-0.15	-0.01
Common Stock Issued	3.11	3.11	6.5	7,774	6.28	0.13
Other Financing Activities	1.03	1.45	0.79	-7,767.04	-	-
Financing Cash Flow	4.13	4.55	7.29	6.96	6.28	0.13
Net Cash Flow	-0.32	-0.36	-3.56	1.17	2.9	-0
Free Cash Flow	-4.46	-4.91	-10.85	-5.79	-3.37	-0.13
Free Cash Flow Margin	-810.90%	-761.06%	-4647.90%	-2752.10%	-1710.74%	-
Free Cash Flow Per Share	-0.03	-0.11	-0.27	-0.16	-0.13	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.